Centers for Disease Control and Prevention
Division of Bacterial Diseases/Respiratory Diseases Branch
Jennifer Verani works in the Respiratory Diseases Branch, Division of Bacterial Diseases at the US Centers for Disease Control and Prevention. She is a pediatrician, epidemiologist, and a Captain in the United States Public Health Service. She obtained her medical degree from Harvard Medical School, MPH in International Health from Harvard School of Public Health, and undergraduate degree in International Development from Brown University. Dr. Verani completed residency training at Children’s Hospital of New York-Columbia. Dr. Verani joined CDC as an Epidemic Intelligence Service officer in the Parasitic Diseases Branch in 2006. In 2008, she moved to the Respiratory Diseases Branch, where she focused on the impact and effectiveness of vaccines against pneumonia and invasive bacterial diseases in Latin America and Africa and provided technical assistance for respiratory disease surveillance in low-resource settings. From 2014-2019, Dr. Verani worked for CDC-Kenya, leading the Population-Based Infectious Disease Surveillance platform in Kibera and Asembo, a network of Acute Febrile Illness sentinel surveillance sites, and serving on the expert panel determining cause of death for the Child Health and Mortality Prevention Surveillance Kenya site. In early 2020, Dr. Verani returned to the Respiratory Diseases Branch as Deputy Branch Chief for Science, and was deployed to work on COVID-19 vaccine effectiveness from May 2020 through April 2022. She is also an Adjunct Assistant Professor of Pediatrics at Emory University School of Medicine.

Moderator of 1 Session

Session Type
Plenary Session
Date
Thu, 23.06.2022
Session Time
08:00 - 09:30
Room
Grand Ballroom East
Session Description
Please note: Each presentation is followed by 5 to 10 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.